$OPNT News Article - Opiant Pharmaceuticals Announces Positive Pharmacokinetic, Safety, and Tolerability Results From a Multi-Dose Study for OPNT003, Nasal Nalmefene https://marketwirenews.com/news-releases/opia...40178.html
Opnet Technologies Inc. (OPNT) Stock Research Links
My Twitter: WhyteStocks